Pharming Group N.V.

Healthcare · Biotechnology · Netherlands

Last price 12.23 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 868.47M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kδ inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also dev...